US EditioneHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Curis approved inducement stock options for 84,750 shares of its common stock to two new employees, effective October 1, 2025.
- The exercise price of the stock options matches the closing price of Curis common stock on October 1, 2025.
- The stock options vest over four years, starting with 25% after one year of employment and 6.25% every three months thereafter.
- Curis focuses on developing Emavusertib, an orally available small molecule IRAK4 inhibitor.
69 Articles
69 Articles
abc12/WJRT
eHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AUSTIN, Texas, Oct. 3, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the "Company"), today announced that on October 1, 2025, the Compensation Committee of its Board of Directors granted an inducement restricted…
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
LEXINGTON, Mass., Oct. 3, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that on October 1, 2025, the independent Compensation Committee of…
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on October 1, 2025, it awarded inducement grants to six new employees under Intellia’s 2024 Inducement Plan […] The post Intellia Therapeutics Reports Inducem…
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
